Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving chemotherapy before a donor peripheral blood stem cell transplant helps
stop the growth of cancer cells. It also helps stop the patient's immune system from
rejecting the donor's stem cells. When the healthy stem cells and natural killer (NK) cells
from a donor are infused into the patient they may help the patient's bone marrow make stem
cells, red blood cells, white blood cells, and platelets.
PURPOSE: This clinical trial is studying how well a peripheral stem cell transplant using NK
cells from a donor works in treating patients with relapsed acute myeloid leukemia.